Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE48.3600
- TODAY'S CHANGE (%)0.5400 (1.1292%)
- Bid / Lots19.3200/ 2
- Ask / Lots49.5000/ 1
- Open / Previous Close48.1400 / 47.8200
- Day Range
- 52 Week Range
- Volume384,335
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 1727 | 48.14 |
| 09:36 ET | 200 | 48.68 |
| 09:38 ET | 215 | 48.65 |
| 09:39 ET | 200 | 48.59 |
| 09:41 ET | 1371 | 48.755 |
| 09:43 ET | 8705 | 48.21 |
| 09:45 ET | 400 | 48.53 |
| 09:48 ET | 300 | 48.335 |
| 09:50 ET | 1467 | 48.04 |
| 09:54 ET | 1000 | 46.99 |
| 09:59 ET | 400 | 46.75 |
| 10:01 ET | 3899 | 47 |
| 10:03 ET | 1971 | 47.26 |
| 10:06 ET | 600 | 47.29 |
| 10:08 ET | 200 | 47.3 |
| 10:10 ET | 837 | 47.49 |
| 10:12 ET | 3604 | 47.73 |
| 10:14 ET | 415 | 47.61 |
| 10:19 ET | 2824 | 47.355 |
| 10:24 ET | 900 | 47.43 |
| 10:26 ET | 2109 | 47.79 |
| 10:28 ET | 667 | 47.75 |
| 10:30 ET | 1303 | 48.095 |
| 10:32 ET | 740 | 48.55 |
| 10:33 ET | 200 | 48.77 |
| 10:35 ET | 300 | 48.7942 |
| 10:37 ET | 600 | 48.46 |
| 10:39 ET | 100 | 48.86 |
| 10:42 ET | 840 | 48.065 |
| 10:44 ET | 100 | 48.21 |
| 10:46 ET | 300 | 48.55 |
| 10:48 ET | 500 | 48.41 |
| 10:50 ET | 300 | 47.8 |
| 10:53 ET | 200 | 48.19 |
| 10:55 ET | 700 | 47.91 |
| 10:57 ET | 400 | 47.91 |
| 11:00 ET | 2003 | 48.2299 |
| 11:02 ET | 400 | 48.245 |
| 11:06 ET | 100 | 48.5 |
| 11:08 ET | 500 | 48.5 |
| 11:09 ET | 1785 | 48.3 |
| 11:13 ET | 200 | 48.09 |
| 11:15 ET | 400 | 48.38 |
| 11:18 ET | 300 | 48.22 |
| 11:22 ET | 400 | 48.04 |
| 11:24 ET | 100 | 48.2 |
| 11:26 ET | 400 | 48.06 |
| 11:27 ET | 500 | 48.15 |
| 11:29 ET | 300 | 48.01 |
| 11:33 ET | 500 | 47.97 |
| 11:36 ET | 800 | 48.21 |
| 11:38 ET | 100 | 48.06 |
| 11:40 ET | 1300 | 48.22 |
| 11:44 ET | 600 | 48.079 |
| 11:45 ET | 1400 | 47.94 |
| 11:47 ET | 100 | 47.88 |
| 11:51 ET | 200 | 47.995 |
| 11:54 ET | 100 | 47.835 |
| 11:56 ET | 500 | 47.955 |
| 11:58 ET | 512 | 47.9799 |
| 12:00 ET | 500 | 48.03 |
| 12:03 ET | 900 | 48.145 |
| 12:05 ET | 1526 | 48.05 |
| 12:07 ET | 600 | 48.24 |
| 12:09 ET | 550 | 48.09 |
| 12:12 ET | 1800 | 48.35 |
| 12:14 ET | 300 | 48.5 |
| 12:16 ET | 1000 | 48.345 |
| 12:18 ET | 8258 | 48.41 |
| 12:20 ET | 600 | 48.37 |
| 12:21 ET | 3931 | 48.5 |
| 12:23 ET | 1000 | 48.465 |
| 12:25 ET | 200 | 48.44 |
| 12:27 ET | 600 | 48.41 |
| 12:30 ET | 300 | 48.49 |
| 12:32 ET | 3143 | 48.5 |
| 12:34 ET | 3702 | 48.425 |
| 12:36 ET | 500 | 48.43 |
| 12:38 ET | 500 | 48.43 |
| 12:39 ET | 200 | 48.425 |
| 12:41 ET | 1200 | 48.425 |
| 12:43 ET | 363 | 48.33 |
| 12:48 ET | 1500 | 48.13 |
| 12:50 ET | 1090 | 48.2 |
| 12:54 ET | 600 | 48.305 |
| 12:57 ET | 200 | 48.5 |
| 12:59 ET | 5950 | 48.275 |
| 01:01 ET | 1190 | 48.35 |
| 01:06 ET | 700 | 48.35 |
| 01:08 ET | 553 | 48.39 |
| 01:10 ET | 200 | 48.33 |
| 01:12 ET | 300 | 48.315 |
| 01:14 ET | 300 | 48.47 |
| 01:15 ET | 500 | 48.35 |
| 01:17 ET | 200 | 48.34 |
| 01:19 ET | 400 | 48.345 |
| 01:24 ET | 600 | 48.345 |
| 01:26 ET | 600 | 48.335 |
| 01:28 ET | 1134 | 48.47 |
| 01:30 ET | 200 | 48.43 |
| 01:32 ET | 1709 | 48.44 |
| 01:33 ET | 300 | 48.49 |
| 01:35 ET | 1707 | 48.48 |
| 01:37 ET | 210 | 48.475 |
| 01:39 ET | 17725 | 48.5 |
| 01:42 ET | 700 | 48.51 |
| 01:44 ET | 374 | 48.48 |
| 01:50 ET | 700 | 48.615 |
| 01:51 ET | 100 | 48.77 |
| 01:53 ET | 100 | 48.87 |
| 01:55 ET | 100 | 48.88 |
| 02:00 ET | 100 | 48.83 |
| 02:02 ET | 100 | 48.84 |
| 02:04 ET | 1578 | 48.97 |
| 02:06 ET | 726 | 48.96 |
| 02:09 ET | 600 | 48.93 |
| 02:11 ET | 949 | 48.69 |
| 02:15 ET | 100 | 48.69 |
| 02:18 ET | 100 | 48.67 |
| 02:20 ET | 300 | 48.745 |
| 02:22 ET | 400 | 48.8 |
| 02:24 ET | 2690 | 48.37 |
| 02:27 ET | 300 | 48.335 |
| 02:29 ET | 1400 | 48.49 |
| 02:36 ET | 400 | 48.4025 |
| 02:38 ET | 200 | 48.53 |
| 02:40 ET | 300 | 48.36 |
| 02:42 ET | 200 | 48.38 |
| 02:44 ET | 300 | 48.35 |
| 02:45 ET | 300 | 48.445 |
| 02:47 ET | 200 | 48.445 |
| 02:49 ET | 600 | 48.38 |
| 02:54 ET | 656 | 48.35 |
| 02:58 ET | 200 | 48.2725 |
| 03:00 ET | 300 | 48.33 |
| 03:02 ET | 200 | 48.33 |
| 03:03 ET | 200 | 48.41 |
| 03:05 ET | 300 | 48.32 |
| 03:07 ET | 400 | 48.36 |
| 03:12 ET | 1560 | 48.41 |
| 03:14 ET | 726 | 48.4 |
| 03:18 ET | 2500 | 48.5 |
| 03:20 ET | 2431 | 48.5 |
| 03:21 ET | 1300 | 48.46 |
| 03:23 ET | 700 | 48.37 |
| 03:25 ET | 836 | 48.43 |
| 03:27 ET | 600 | 48.3978 |
| 03:30 ET | 1100 | 48.305 |
| 03:32 ET | 500 | 48.25 |
| 03:34 ET | 2725 | 48.35 |
| 03:38 ET | 200 | 48.25 |
| 03:39 ET | 500 | 48.135 |
| 03:41 ET | 920 | 47.951 |
| 03:43 ET | 3545 | 48.255 |
| 03:45 ET | 200 | 48.255 |
| 03:48 ET | 700 | 48.25 |
| 03:50 ET | 2770 | 48.06 |
| 03:52 ET | 3546 | 48.29 |
| 03:54 ET | 622 | 48.345 |
| 03:56 ET | 5560 | 48.435 |
| 03:57 ET | 4397 | 48.26 |
| 03:59 ET | 59564 | 48.36 |
Aug 19, 2024
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases, from 7:00AM ET on Monday Aug 19, 2024 by Dow Jones
7:00AM ET on Monday Aug 19, 2024 by Dow Jones
Aug 12, 2024
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results, from 6:30AM ET on Monday Aug 12, 2024 by Dow Jones
6:30AM ET on Monday Aug 12, 2024 by Dow JonesPress Release: Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results, from 6:30AM ET on Monday Aug 12, 2024 by Dow Jones
6:30AM ET on Monday Aug 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 2.8B | -21.5x | --- |
Geron Corp | 2.7B | -12.6x | --- |
Immunitybio Inc | 2.9B | -4.5x | --- |
Xenon Pharmaceuticals Inc | 2.9B | -14.9x | --- |
SpringWorks Therapeutics Inc | 3.0B | -9.3x | --- |
MoonLake Immunotherapeutics | 3.1B | -55.0x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark Mckenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Lisa Bollinger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.25 |
Book Value | $7.86 |
P/E Ratio | -21.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
